TRIUS THERAPEUTICS INC COM STK (DE)
TSRX
TSRX was delisted on the 11th of September, 2013.
0 hedge funds and large institutions have $0 invested in TRIUS THERAPEUTICS INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $54K → $0 (-$54K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Amici Capital
New York
|
-$54K |
TSRX Hedge Fund Activity: Q1 2014 in Review
0 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) for Q1 2014, worth a combined $0 — down 100% from $54K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TSRX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Amici Capital, exiting entirely with an estimated $54K sold.
- 0 institutional investors held TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) as of Q1 2014, down from 1 in Q4 2013.
- Funds reported $0 of TRIUS THERAPEUTICS INC COM STK (DE) stock for Q1 2014, down 100% quarter-over-quarter.
- 0 funds opened new TRIUS THERAPEUTICS INC COM STK (DE) positions in Q1 2014 and 1 closed out, a net change of -1 holder.
- The largest TRIUS THERAPEUTICS INC COM STK (DE) seller in Q1 2014 was Amici Capital, an estimated $54K sold.
Based on aggregated 13F filings for Q1 2014.